Henan Taloph Pharmaceutical Stock Co. Ltd.SSE: 600222

Announcement on Change of "Drug Manufacturing License"

· Issued by Henan Taloph Pharmaceutical Stock Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Henan Taloph Pharmaceutical Stock Co. Ltd. announced a change in its "Drug Manufacturing License." The company received a renewed license from the Henan Provincial Drug Administration, which includes changes to its production scope and lines. The new license is valid until the end of a specified year and outlines the company's production capabilities. The announcement also includes a risk warning regarding potential impacts from industry regulations and market changes.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix

Earlier from Henan Taloph Pharmaceutical Stock

Later from Henan Taloph Pharmaceutical Stock

All Henan Taloph Pharmaceutical Stock news releases